Press Releases
-
January 05, 2023
Omnicell to Present at the 41st Annual J.P. Morgan Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced that they will present at the 41 st Annual J.P. Morgan Healthcare Conference on Wednesday,...
-
December 05, 2022
Omnicell to Showcase Advanced Services Designed to Deliver Enhanced Medication Management Outcomes at ASHP Midyear 2022
Advanced Services combine innovative technology, expertise, and intelligence intended to support business and clinical outcomes across all settings of care Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication...
-
November 23, 2022
Omnicell to Present at the Piper Sandler 34th Annual Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conference: Randall Lipps, Omnicell Chairman,...
-
November 02, 2022
Omnicell Announces Financial Results for Third Quarter 2022
GAAP and non-GAAP revenues of $348 million G AAP net income per diluted share of $0.37 Non-GAAP net income per diluted share of $1.00 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leading provider of...
-
October 13, 2022
Omnicell to Release Third Quarter 2022 Financial Results on November 2, 2022
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2022, before market on Wednesday, November 2,...
-
October 11, 2022
Omnicell Launches Specialty Pharmacy Services to Support Optimized Outpatient Medication Management and Drive Clinical and Business Outcomes for Health Systems
Summer 2022 Release features new services and solution enhancements designed to improve safety and efficiency and generate value for customers across the continuum of care Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell”), a leading provider of medication...
-
September 20, 2022
Omnicell Highlights Differentiated Strategy and Unique Business Model at 2022 Investor Day
Advanced Services Business Model Driving Growth Opportunities and Recurring, High Visibility Revenue Well Positioned in Large and Growing Market Segments Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leading provider of medication...
-
August 31, 2022
Omnicell to Present at the 2022 Wells Fargo Healthcare Conference
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, announced its participation in the upcoming investor conference: Scott Seidelmann, Omnicell Executive Vice...
-
August 25, 2022
Omnicell to Host Investor Day on September 20, 2022
Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today announced that it will host an Investor Day on September 20, 2022 at 1:00 p.m. Eastern Time. The Investor Day...
-
August 04, 2022
Omnicell Announces Financial Results for Second Quarter 2022
GAAP revenues of $331 million and non-GAAP revenues of $332 million GAAP net income per diluted share of $0.20 Non-GAAP net income per diluted share of $0.84 Second quarter results reflect an impact from the previously disclosed ransomware incident;...
-
July 11, 2022
Omnicell to Release Second Quarter 2022 Financial Results on August 4, 2022
Omnicell, Inc. (Nasdaq :OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2022, after market on Thursday, August 4, 2022....
-
April 28, 2022
Omnicell Announces Financial Results for First Quarter 2022
GAAP and non-GAAP revenues of $319 million GAAP net income per diluted share of $0.17 Non-GAAP net income per diluted share of $0.83 Launched innovative IVX Station robotic compounding technology Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,”...
-
April 05, 2022
Omnicell to Release First Quarter 2022 Financial Results on April 28, 2022
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2022, after market on Thursday, April 28, 2022....
-
March 29, 2022
Omnicell Unveils Innovative IVX Station Robotic Compounding Technology in Winter 2022 Release
New Technology and Enhancements to Intelligent Infrastructure Designed to Support Safer, Smarter Pharmacy Care Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and adherence tools for health systems and pharmacies, today...
-
March 01, 2022
Omnicell Announces Changes to Its Board of Directors
Omnicell Intends to Nominate Mary Garrett for Election to Board of Directors at 2022 Annual Meeting of Stockholders Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management solutions and adherence tools for health systems and...
-
February 14, 2022
UMC Health System Partners with Omnicell for Advanced Services Solutions to Streamline Medication Management and Enhance Clinical and Operational Outcomes
Combination of cloud-based technology, 340B program management, and EnlivenHealth® patient engagement solutions will drive key initiatives for Texas-based health system Omnicell, Inc. (Nasdaq: OMCL), a leading provider of medication management and...